Makani Science Secures $45K Seed Round to Pioneer the World’s First Continuous Respiration Monitor

Makani Science is excited to announce that we have successfully raised $45,000 in our latest funding round, marking an important milestone in our journey toward revolutionizing respiratory health monitoring. As an innovative company, we are dedicated to designing a small, wireless wearable respiratory monitor that employs cutting-edge, stretchable electronic sensors. Our vision is ambitious—we are on a path to develop the world's first Continuous Respiration Monitor, a breakthrough technology that has the potential to transform the way respiratory conditions are managed and monitored. This infusion of capital is a significant vote of confidence in our technical approach and our commitment to improving patient outcomes. With these funds, we will accelerate research and development, refine our sensor technology, and enhance the overall design of our wearable system. Additionally, the investment will support key initiatives, including scaling our pilot testing program and expanding our team of expert engineers and healthcare professionals who share our vision for a future where continuous respiratory monitoring is within everyone's reach. We firmly believe that this innovative solution will not only provide critical real-time insights into respiratory health but also pave the way for advanced, data-driven care strategies. As we embark on this exciting phase of growth, we remain dedicated to pushing the boundaries of what is possible in healthcare technology, ensuring that our products deliver both reliability and transformative impact. We are immensely grateful to our investors and supporters who have recognized the potential in our technology, and we look forward to sharing further updates as we advance towards a future of improved respiratory monitoring and better health outcomes for all.